Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials is a research paper published in PLOS Global Public Health (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Malawi HIV Implementation Research Scientist Training (M-HIRST) program
Grant: 5D43TW010060
ACTG-SDAC Internship program
Grant: UM1 AI068634
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: UM1 AI068636
National Institute of Allergy and Infectious Diseases of the National Institutes of Health
Grant: UM1 AI106701
NIAID NIH HHS
Grant: UM1 AI069453
NIAID NIH HHS
Grant: U01 AI069463
NIAID NIH HHS
Grant: P30 AI050410
NIAID NIH HHS
Grant: UM1 AI069463
NIAID NIH HHS
Grant: U01 AI068636
NIAID NIH HHS
Grant: UM1 AI069423
FIC NIH HHS
Grant: D43 TW010060
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
Grant: 5UM1AI068634-09
Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG)
National Institutes of Health
Grant: 5D43TW010060-10
Malawi HIV Implementation Research Scientist Training Program (M-HIRST)
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Fields of Study
Keywords
Sustainable Development Goals